A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
Connell SP, Yazbek-Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium; Parker C, Brewer DS, Cooper CS, Clark J.
Connell SP, et al. Among authors: mills r, mills ig.
BJU Int. 2019 Oct;124(4):609-620. doi: 10.1111/bju.14811. Epub 2019 Jun 25.
BJU Int. 2019.
PMID: 31106513
Free PMC article.